Health Trials

FGFR2 Fusion

1

Review clinical trials related to FGFR2 Fusion. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Phase I/II Trial of Pemigatinib in Combination With Atezolizumab and Bevacizumab for Treatment of Advanced Cholangiocarcinoma With FGFR2 Fusion

To learn if pemigatinib in combination with atezolizumab and bevacizumab can help to control cholangiocarcinoma.

Participants needed: 25
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: M.D. Anderson Cancer CenterUpdated: Jan 14, 2026Locations: 1
Eligibility criteria

Ability to understand and willingness to sign informed consent. [+30]

Received prior chemotherapy, biologic therapy, immunotherapy, or investigational... [+49]

Read more